ID

25803

Beschrijving

Testing Strategies to Improving Warfarin Adherence; ODM derived from: https://clinicaltrials.gov/show/NCT00622102

Link

https://clinicaltrials.gov/show/NCT00622102

Trefwoorden

Versies (1)
  1. 20-09-17 20-09-17 -
Geüploaded op

20 september 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Atrial Fibrillation NCT00622102

Engels

Eligibility Atrial Fibrillation NCT00622102

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
21 years old age or older
Beschrijving

Age

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
on warfarin managed at the ac clinic
Beschrijving

on warfarin

Datatype

boolean

Alias
UMLS CUI [1]
C0851145
target inr 2.0-3.0 or 2.5-3.5
Beschrijving

Target international normalized ratio

Datatype

boolean

Alias
UMLS CUI [1]
C1272307
at maintenance phase of therapy (defined as stable inr with stable warfarin dosing over at least 2 consecutive visits)
Beschrijving

Therapeutic procedure Maintenance Phase | INR Stable | Warfarin Dosage Stable

Datatype

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0024501
UMLS CUI [1,3]
C0205390
UMLS CUI [2,1]
C0525032
UMLS CUI [2,2]
C0205360
UMLS CUI [3,1]
C0043031
UMLS CUI [3,2]
C0178602
UMLS CUI [3,3]
C0205360
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
do not have access to telephone line
Beschrijving

Access to telephone Lacking

Datatype

boolean

Alias
UMLS CUI [1,1]
C1822200
UMLS CUI [1,2]
C0332268
unwillingness to participate or to sign a consent form(refusal)
Beschrijving

Study Subject Participation Status Unwilling | Informed Consent Refused

Datatype

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C0558080
UMLS CUI [2,1]
C0021430
UMLS CUI [2,2]
C1705116
inability to participate because of advances dementia, advanced alzheimer's disease or other impairment affecting ability to provide informed consent and/or quality data or utilize the med-emonitor
Beschrijving

Study Subject Participation Status Unable | Dementia Advanced | Alzheimer's Disease Advanced | Impairment Affecting Informed Consent | Impairment Affecting Data Quality | Impairment Affecting Medical care

Datatype

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C1299582
UMLS CUI [2,1]
C0497327
UMLS CUI [2,2]
C0205179
UMLS CUI [3,1]
C0002395
UMLS CUI [3,2]
C0205179
UMLS CUI [4,1]
C0221099
UMLS CUI [4,2]
C0392760
UMLS CUI [4,3]
C0021430
UMLS CUI [5,1]
C0221099
UMLS CUI [5,2]
C0392760
UMLS CUI [5,3]
C0242483
UMLS CUI [6,1]
C0221099
UMLS CUI [6,2]
C0392760
UMLS CUI [6,3]
C0496675
participation in a current study that does not permit participation in another study
Beschrijving

Study Subject Participation Status Illicit

Datatype

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C0332266
end stage or terminal illness with anticipated life expectancy of 6 months or less
Beschrijving

Terminal illness | Life Expectancy

Datatype

boolean

Alias
UMLS CUI [1]
C0679247
UMLS CUI [2]
C0023671
inr over the upper limit for the individual's range at the time of enrollment (e.g.,>3.0 or >3.5, depending on the target range)
Beschrijving

INR raised

Datatype

boolean

Alias
UMLS CUI [1]
C0853225
diagnosed with antiphospholipid antibody syndrome or abnormal inr prior to starting warfarin
Beschrijving

Antiphospholipid Syndrome | INR abnormal

Datatype

boolean

Alias
UMLS CUI [1]
C0085278
UMLS CUI [2]
C0580417
Terug naar het begin van de pagina

Similar models

Eligibility Atrial Fibrillation NCT00622102

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
21 years old age or older
boolean
C0001779 (UMLS CUI [1])
on warfarin
Item
on warfarin managed at the ac clinic
boolean
C0851145 (UMLS CUI [1])
Target international normalized ratio
Item
target inr 2.0-3.0 or 2.5-3.5
boolean
C1272307 (UMLS CUI [1])
Therapeutic procedure Maintenance Phase | INR Stable | Warfarin Dosage Stable
Item
at maintenance phase of therapy (defined as stable inr with stable warfarin dosing over at least 2 consecutive visits)
boolean
C0087111 (UMLS CUI [1,1])
C0024501 (UMLS CUI [1,2])
C0205390 (UMLS CUI [1,3])
C0525032 (UMLS CUI [2,1])
C0205360 (UMLS CUI [2,2])
C0043031 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0205360 (UMLS CUI [3,3])
Item Group
C0680251 (UMLS CUI)
Access to telephone Lacking
Item
do not have access to telephone line
boolean
C1822200 (UMLS CUI [1,1])
C0332268 (UMLS CUI [1,2])
Study Subject Participation Status Unwilling | Informed Consent Refused
Item
unwillingness to participate or to sign a consent form(refusal)
boolean
C2348568 (UMLS CUI [1,1])
C0558080 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2,1])
C1705116 (UMLS CUI [2,2])
Study Subject Participation Status Unable | Dementia Advanced | Alzheimer's Disease Advanced | Impairment Affecting Informed Consent | Impairment Affecting Data Quality | Impairment Affecting Medical care
Item
inability to participate because of advances dementia, advanced alzheimer's disease or other impairment affecting ability to provide informed consent and/or quality data or utilize the med-emonitor
boolean
C2348568 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C0497327 (UMLS CUI [2,1])
C0205179 (UMLS CUI [2,2])
C0002395 (UMLS CUI [3,1])
C0205179 (UMLS CUI [3,2])
C0221099 (UMLS CUI [4,1])
C0392760 (UMLS CUI [4,2])
C0021430 (UMLS CUI [4,3])
C0221099 (UMLS CUI [5,1])
C0392760 (UMLS CUI [5,2])
C0242483 (UMLS CUI [5,3])
C0221099 (UMLS CUI [6,1])
C0392760 (UMLS CUI [6,2])
C0496675 (UMLS CUI [6,3])
Study Subject Participation Status Illicit
Item
participation in a current study that does not permit participation in another study
boolean
C2348568 (UMLS CUI [1,1])
C0332266 (UMLS CUI [1,2])
Terminal illness | Life Expectancy
Item
end stage or terminal illness with anticipated life expectancy of 6 months or less
boolean
C0679247 (UMLS CUI [1])
C0023671 (UMLS CUI [2])
INR raised
Item
inr over the upper limit for the individual's range at the time of enrollment (e.g.,>3.0 or >3.5, depending on the target range)
boolean
C0853225 (UMLS CUI [1])
Antiphospholipid Syndrome | INR abnormal
Item
diagnosed with antiphospholipid antibody syndrome or abnormal inr prior to starting warfarin
boolean
C0085278 (UMLS CUI [1])
C0580417 (UMLS CUI [2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial